PYC Therapeutics Ltd - ESG Rating & Company Profile powered by AI
If you work at PYC Therapeutics Ltd and you wish to licence your Sustainability aseessment, please get in touch. This report of PYC Therapeutics Ltd was prepared by All Street Sevva using advanced NLP. This webpage includes a questions and answers table for PYC Therapeutics Ltd.
PYC Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.0, social score of 6.4 and governance score of 4.8.
5.1
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
687 | Valbiotis SA | 5.2 | High |
687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
724 | PYC Therapeutics Ltd | 5.1 | High |
724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
724 | Adverum Biotechnologies Inc | 5.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does PYC Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Does PYC Therapeutics Ltd disclose current and historical energy intensity?
Does PYC Therapeutics Ltd report the average age of the workforce?
Does PYC Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Does PYC Therapeutics Ltd disclose its ethnicity pay gap?
Does PYC Therapeutics Ltd disclose cybersecurity risks?
Does PYC Therapeutics Ltd offer flexible work?
Does PYC Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does PYC Therapeutics Ltd disclose the number of employees in R&D functions?
Does PYC Therapeutics Ltd conduct supply chain audits?
Does PYC Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does PYC Therapeutics Ltd conduct 360 degree staff reviews?
Does PYC Therapeutics Ltd disclose the individual responsible for D&I?
Does PYC Therapeutics Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does PYC Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Does PYC Therapeutics Ltd disclose water use targets?
Does PYC Therapeutics Ltd have careers partnerships with academic institutions?
Did PYC Therapeutics Ltd have a product recall in the last two years?
Does PYC Therapeutics Ltd disclose incidents of discrimination?
Does PYC Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Has PYC Therapeutics Ltd issued a profit warning in the past 24 months?
Does PYC Therapeutics Ltd disclose parental leave metrics?
Does PYC Therapeutics Ltd disclose climate scenario or pathway analysis?
Does PYC Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does PYC Therapeutics Ltd disclose the pay ratio of women to men?
Does PYC Therapeutics Ltd support suppliers with sustainability related research and development?
Does PYC Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does PYC Therapeutics Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is PYC Therapeutics Ltd involved in embryonic stem cell research?
Does PYC Therapeutics Ltd disclose GHG and Air Emissions intensity?
Does PYC Therapeutics Ltd disclose its waste policy?
Does PYC Therapeutics Ltd report according to TCFD requirements?
Does PYC Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does PYC Therapeutics Ltd disclose energy use targets?
Does PYC Therapeutics Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does PYC Therapeutics Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for PYC Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.